The Wisconsin Parkinson’s Association held its second annual Pitching for Parkinson’s event on Thursday in Grand Chute as ...

AbbVie said on Thursday its drug met the main goal in a late-stage trial in patients with early Parkinson's disease.

Annovis Bio saw promising results for Buntanetap in treating Alzheimer's and Parkinson's, but short cash runway prompts a ...

Brett Favre revealed the symptoms and rationale behind his Parkinson's disease diagnosis in a newly published interview.

A tremor that won’t stop, slow movements, rigid muscles they’re the classic signs of Parkinson’s disease that alert doctors ...

AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That ...

Green Bay Packers quarterback, said he has the brain disorder Parkinson's disease, likely caused by countless concussions.

AbbVie (ABBV) said its Phase 3 trial TEMPO-1 for experimental therapy Tavapadon reached main goal in Parkinson's disease.

AbbVie reports positive Phase 3 results for tavapadon, a once-daily treatment for early-stage Parkinson's disease. The drug ...

Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its ...

Researchers at UAB found blows to the head, like football players regularly experience, play a “significant” role in a person ...

All of a sudden, the health benefits of coffee has become a hot topic. Now comes a new study that suggests people are ...